CL
NUVB icon

Choreo LLC’s Nuvation Bio NUVB Stock Holding History

Choreo LLC’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,712
Closed -$123K – 1680
2025
Q4 		$123K Buy
13,712
+718
+6% +$4.45K ﹤0.01% 1498
2025
Q3 		$48.1K Hold
12,994
– – ﹤0.01% 1532
2025
Q2 		$25.3K Sell
12,994
-1,817
-12% -$3.79K ﹤0.01% 1510
2025
Q1 		$26.1K Sell
14,811
-1,609
-10% -$3.66K ﹤0.01% 1412
2024
Q4 		$43.5K Buy
16,420
+323
+2% +$832 ﹤0.01% 1545
2024
Q3 		$37K Buy
16,097
+1,286
+9% +$3.92K ﹤0.01% 1585
2024
Q2 		$46.8K Buy
+14,811
New +$45.2K ﹤0.01% 1445
2023
Q2 		– Sell
-12,994
Closed -$21.6K – 489
2023
Q1 		$21.6K Hold
12,994
– – ﹤0.01% 475
2022
Q4 		$29.5K Buy
+12,994
New +$26.3K ﹤0.01% 234

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Choreo LLC's NUVB Position: Q1 2026 in Review

Choreo LLC sold out of Nuvation Bio (NUVB) in Q1 2026, closing a stake of 13,712 shares — an estimated $123K sold.

Choreo LLC first reported a position in NUVB in Q4 2022 and held it in 9 quarters. The position peaked at $123K in Q4 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Choreo LLC reported no remaining Nuvation Bio position as of Q1 2026 after selling out during the quarter.
  • Choreo LLC sold 13,712 Nuvation Bio shares in Q1 2026, an estimated $123K.
  • Choreo LLC first reported a position in Nuvation Bio in Q4 2022 and held it in 9 quarters.
  • Choreo LLC's Nuvation Bio position peaked at $123K in Q4 2025.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Choreo LLC's 13F filing for Q1 2026, filed 13 May 2026.